Anti-CCNE1 antibody produced in rabbit
SIGMA/SAB1400044 - IgG fraction of antiserum, buffered aqueous solution
Synonym: Anti-CCNE
Product Type: Chemical
Proximity Ligation Assay Proximity Ligation Analysis of protein-protein interactions between CCNE1 and CDKN1A. HeLa cells were stained with anti-CCNE1 rabbit purified polyclonal 1:1200 and anti-CDKN1A mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).
Western Blotting Western Blot analysis of CCNE1 expression in transfected 293T cell line by CCNE1 polyclonal antibody. Lanes Lane 1: CCNE1 transfected lysate (47.10 kDa). Lane 2: Non-transfected lysate.
Western Blotting CCNE1 rabbit polyclonal antibody. Western Blot analysis of CCNE1 expression in mouse liver.
| antibody form | IgG fraction of antiserum |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| Quality Level | 100  |
| shipped in | dry ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | proximity ligation assay: suitable |
| western blot: 1 μg/mL | |
| UniProt accession no. | P24864  |
| Biochem/physiol Actions: | Elevated expression of Cyclin E1 (CCNE1) results in ovarian cancer. Thus, CCNE1 can be considered as a potential therapeutic target in ovarian cancer. CCNE1 might act as a key functional mediator in G1/S transition and is considered to be a one of new direct target genes of microRNA (miRNA) precursor mir-7 in human hepatocellular carcinoma (HCC). |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | Cyclin E1 (CCNE1) is encoded by the gene mapped to human chromosome 19q12–q21. |
| General description: | The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Overexpression of this gene has been observed in many tumors, which results in chromosome instability, and thus may contribute to tumorigenesis. This protein was found to associate with, and be involved in, the phosphorylation of NPAT protein (nuclear protein mapped to the ATM locus), which participates in cell-cycle regulated histone gene expression and plays a critical role in promoting cell-cycle progression in the absence of pRB. Two alternatively spliced transcript variants of this gene, which encode distinct isoforms, have been described. Two additional splice variants were reported but detailed nucleotide sequence information is not yet available. (provided by RefSeq) |
| Immunogen: | CCNE1 (NP_001229.1, 1 a.a. ~ 410 a.a) full-length human protein. Sequence MPRERRERDAKERDTMKEDGGAEFS |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |